Neurotek. Consulta y laboratorio de Disautonomía

22/08/2026

Fibromyalgia is characterized by widespread pain involving any body tissue and typically accompanied by fatigue and problems with sleep, mood, and memory. Fibromyalgia can occur alone or in combina...

03/08/2026

The August Sleep Neurology issue, guest edited by Dr. Karin Johnson, is now available at https://hubs.ly/Q04rGvdl0!

25/06/2026

Approximately 25 000 people in the US live with , a condition with typical onset after age 40 and rapid progression.

Most patients experience muscle weakness, fatigue, and difficulties with speech, swallowing, or breathing.

📝 This JAMA Patient Page describes how common ALS is and who is typically affected along with information about the diagnosis, treatment, and prognosis of ALS.

https://ja.ma/4oKQ7X7

23/06/2026

In the last decade, the field of Alzheimer’s disease has seen transformative advances that are beginning to reshape clinical practice.

In a new Seminar, authors summarise the progress made and highlight the unmet needs and priorities for future research ▶️ http://spkl.io/61827E9pK

👇 Figure: Neuropathological characteristics and stages of Alzheimer's disease.

20/06/2026

Un poco de luz en el tratamiento de AMS

For too long, Multiple Systems Atrophy (MSA) patients faced a road ...

16/06/2026

Low back pain is defined as pain located below the costal margin and above the inferior gluteal folds, with or without leg pain and is the leading cause of years lived with worldwide, affecting people of all ages.

📝 This JAMA Review summarizes the epidemiology, pathophysiology, clinical evaluation, prognosis, and treatment of nonspecific low back pain in the outpatient setting.

https://ja.ma/4fNMtt4

10/06/2026

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive weakness due to degeneration of upper motor neurons in the brain and lower motor neurons in the brainstem and spinal cord. It affects approximately 25 000 individuals in the United States.

Amyotrophic lateral sclerosis is characterized by progressive painless muscle weakness that typically begins in a focal region of the body, such as limb muscle weakness causing hand weakness or foot drop, cranial muscle weakness causing speech or swallowing problems, or axial muscle weakness causing bent posture, and spreads to other body regions over time.

No curative therapies exist for ALS. Two oral medications, riluzole and edaravone, have been approved by the FDA and modestly decrease disease progression in sALS (by 2-4 months).Tofersen, an intrathecally administered gene based therapy, is also FDA approved and slows disease progression in patients with SOD1 pathogenic gene variants.

This Review summarizes current evidence regarding the diagnosis and treatment of ALS.

https://ja.ma/4vxLlOB

09/06/2026

Benign paroxysmal positional vertigo (BPPV) is an inner ear disorder that causes brief episodes of vertigo, which is a spinning sensation that occurs without movement.

This JAMA Patient Page describes common symptoms and causes of benign paroxysmal positional vertigo, risk factors, and diagnosis and treatment.

https://ja.ma/4fvKJEA

06/06/2026